Pharmaceutical Crystals. / Volume II / / Etsuo Yonemochi, Hidehiro Uekusa, editor.
The crystalline state is the most commonly used as an essential solid in active pharmaceutical ingredients (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines. Still, the core is crystal structure analysis, which reveals the molecular structure of essential...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2023. |
Year of Publication: | 2023 |
Language: | English |
Physical Description: | 1 online resource (176 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993599253104498 |
---|---|
ctrlnum |
(CKB)5700000000354315 (NjHacI)995700000000354315 (EXLCZ)995700000000354315 |
collection |
bib_alma |
record_format |
marc |
spelling |
Pharmaceutical Crystals. Volume II / Etsuo Yonemochi, Hidehiro Uekusa, editor. Pharmaceutical Crystals Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2023. 1 online resource (176 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. The crystalline state is the most commonly used as an essential solid in active pharmaceutical ingredients (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines. Still, the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. These properties should be understood in terms of molecular structures and interactions between molecules in crystals. Information on three-dimensional molecular structures also affords insights into the biological activity of molecules. The second reprint in the series, "Crystalline Pharmaceuticals (Volume II)" focused on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts and hydrates, and polymorph crystals, were reported with interest. Such crystal structures contributed to the latest studies that combine morphology, spectroscopic, theoretical calculation, and thermal analysis with the crystallographic study. Thus, this reprint highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure-property study of pharmaceutical crystals. The Guest Editors of this reprint hope the readers enjoy a wide variety of recent studies on "Crystalline Pharmaceuticals." Pharmaceutical chemistry. 3-0365-5473-4 Uekusa, Hidehiro, editor. Yonemochi, Etsuo, editor. |
language |
English |
format |
eBook |
author2 |
Uekusa, Hidehiro, Yonemochi, Etsuo, |
author_facet |
Uekusa, Hidehiro, Yonemochi, Etsuo, |
author2_variant |
h u hu e y ey |
author2_role |
TeilnehmendeR TeilnehmendeR |
title |
Pharmaceutical Crystals. |
spellingShingle |
Pharmaceutical Crystals. |
title_full |
Pharmaceutical Crystals. Volume II / Etsuo Yonemochi, Hidehiro Uekusa, editor. |
title_fullStr |
Pharmaceutical Crystals. Volume II / Etsuo Yonemochi, Hidehiro Uekusa, editor. |
title_full_unstemmed |
Pharmaceutical Crystals. Volume II / Etsuo Yonemochi, Hidehiro Uekusa, editor. |
title_auth |
Pharmaceutical Crystals. |
title_alt |
Pharmaceutical Crystals |
title_new |
Pharmaceutical Crystals. |
title_sort |
pharmaceutical crystals. |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2023 |
physical |
1 online resource (176 pages) |
isbn |
3-0365-5474-2 3-0365-5473-4 |
callnumber-first |
Q - Science |
callnumber-subject |
QD - Chemistry |
callnumber-label |
QD921 |
callnumber-sort |
QD 3921 P437 42023 |
illustrated |
Not Illustrated |
dewey-hundreds |
500 - Science |
dewey-tens |
540 - Chemistry |
dewey-ones |
548 - Crystallography |
dewey-full |
548 |
dewey-sort |
3548 |
dewey-raw |
548 |
dewey-search |
548 |
work_keys_str_mv |
AT uekusahidehiro pharmaceuticalcrystalsvolumeii AT yonemochietsuo pharmaceuticalcrystalsvolumeii AT uekusahidehiro pharmaceuticalcrystals AT yonemochietsuo pharmaceuticalcrystals |
status_str |
n |
ids_txt_mv |
(CKB)5700000000354315 (NjHacI)995700000000354315 (EXLCZ)995700000000354315 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Pharmaceutical Crystals. |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796653152476332032 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02638nam a2200301 i 4500</leader><controlfield tag="001">993599253104498</controlfield><controlfield tag="005">20230704093135.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230704s2023 sz o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-0365-5474-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5700000000354315</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995700000000354315</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995700000000354315</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QD921</subfield><subfield code="b">.P437 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">548</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Pharmaceutical Crystals.</subfield><subfield code="n">Volume II /</subfield><subfield code="c">Etsuo Yonemochi, Hidehiro Uekusa, editor.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Pharmaceutical Crystals </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (176 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The crystalline state is the most commonly used as an essential solid in active pharmaceutical ingredients (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines. Still, the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. These properties should be understood in terms of molecular structures and interactions between molecules in crystals. Information on three-dimensional molecular structures also affords insights into the biological activity of molecules. The second reprint in the series, "Crystalline Pharmaceuticals (Volume II)" focused on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts and hydrates, and polymorph crystals, were reported with interest. Such crystal structures contributed to the latest studies that combine morphology, spectroscopic, theoretical calculation, and thermal analysis with the crystallographic study. Thus, this reprint highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure-property study of pharmaceutical crystals. The Guest Editors of this reprint hope the readers enjoy a wide variety of recent studies on "Crystalline Pharmaceuticals."</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical chemistry.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-5473-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Uekusa, Hidehiro,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yonemochi, Etsuo,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:20:33 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-04-02 14:12:45 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345554460004498&Force_direct=true</subfield><subfield code="Z">5345554460004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345554460004498</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345668830004498&Force_direct=true</subfield><subfield code="Z">5345668830004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345668830004498</subfield></datafield></record></collection> |